Immune diagnosis of paraneoplastic neurological disease.
A continuous stream of new information on clinical, pathological and immunological aspects of paraneoplastic neurological syndromes has been published in recent years. In this survey, we will discuss current opinions on the value of anti-neuronal antibody detection for establishing a diagnosis of one of the paraneoplastic syndromes of the central nervous system.
Moll
J W
JW
Department of Neuro-Oncology and Neurology, Dr. Daniel den Hoed Cancer Center, Rotterdam, Netherlands.
Vecht
C J
CJ
D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000276:immunology*; D001327:Autoimmune Diseases / Q000175:diagnosis* / Q000276:immunology; D002526:Cerebellar Diseases / Q000175:diagnosis / Q000276:immunology; D051959:ELAV Proteins; D004679:Encephalomyelitis / Q000175:diagnosis / Q000276:immunology; D006801:Humans; D009207:Myoclonus / Q000175:diagnosis / Q000276:immunology; D009410:Nerve Degeneration / Q000276:immunology; D009419:Nerve Tissue Proteins; D009422:Nervous System Diseases / Q000175:diagnosis* / Q000276:immunology; D015835:Ocular Motility Disorders / Q000175:diagnosis / Q000276:immunology; D010257:Paraneoplastic Syndromes / Q000175:diagnosis* / Q000276:immunology; D016601:RNA-Binding Proteins / Q000276:immunology; D012678:Sensation Disorders / Q000175:diagnosis / Q000276:immunology
D001323:Autoantibodies; D001324:Autoantigens; D051959:ELAV Proteins; D009419:Nerve Tissue Proteins; D016601:RNA-Binding Proteins